Cannell & Spears’s CVS Health CVS Stock Holding History

Cannell & Spears’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,995	Closed	-$797K	–	374
2024 Q1	$797K	Buy	9,995 +1,980	+25%	+$151K	0.02%	245
2023 Q4	$633K	Sell	8,015 -75	-0.9%	-$5.34K	0.05%	125
2023 Q3	$565K	Hold	8,090	–	–	0.05%	125
2023 Q2	$559K	Sell	8,090 -2,310	-22%	-$164K	0.05%	133
2023 Q1	$773K	Sell	10,400 -5,515	-35%	-$462K	0.07%	103
2022 Q4	$1.48M	Buy	15,915 +400	+3%	+$38.6K	0.14%	70
2022 Q3	$1.48M	Sell	15,515 -50	-0.3%	-$4.95K	0.15%	68
2022 Q2	$1.44M	Hold	15,565	–	–	0.13%	77
2022 Q1	$1.57M	Sell	15,565 -1,000	-6%	-$105K	0.12%	82
2021 Q4	$1.71M	Buy	16,565 +2,000	+14%	+$185K	0.12%	81
2021 Q3	$1.24M	Sell	14,565 -120	-0.8%	-$10.1K	0.09%	85
2021 Q2	$1.23M	Sell	14,685 -3,475	-19%	-$285K	0.09%	90
2021 Q1	$1.37M	Sell	18,160 -403	-2%	-$29.4K	0.11%	82
2020 Q4	$1.27M	Sell	18,563 -400	-2%	-$26K	0.11%	85
2020 Q3	$1.11M	Sell	18,963 -56	-0.3%	-$3.48K	0.11%	82
2020 Q2	$1.24M	Buy	19,019 +56	+0.3%	+$3.53K	0.13%	75
2020 Q1	$1.13M	Sell	18,963 -975	-5%	-$65.1K	0.14%	74
2019 Q4	$1.48M	Buy	19,938 +113	+0.6%	+$7.93K	0.16%	53
2019 Q3	$1.25M	Sell	19,825 -300	-1%	-$17.8K	0.15%	54
2019 Q2	$1.1M	Buy	20,125 +6,690	+50%	+$360K	0.13%	63
2019 Q1	$725K	Buy	13,435 +560	+4%	+$34.6K	0.09%	78
2018 Q4	$844K	Buy	12,875 +350	+3%	+$26.1K	0.12%	67
2018 Q3	$986K	Sell	12,525 -400	-3%	-$28.6K	0.12%	69
2018 Q2	$832K	Hold	12,925	–	–	0.11%	71
2018 Q1	$804K	Hold	12,925	–	–	0.1%	72
2017 Q4	$937K	Hold	12,925	–	–	0.11%	68
2017 Q3	$1.05M	Hold	12,925	–	–	0.13%	59
2017 Q2	$1.04M	Hold	12,925	–	–	0.13%	54
2017 Q1	$1.01M	Sell	12,925 -10,635	-45%	-$849K	0.13%	54
2016 Q4	$1.86M	Hold	23,560	–	–	0.24%	37
2016 Q3	$2.1M	Sell	23,560 -600	-2%	-$56.6K	0.26%	35
2016 Q2	$2.31M	Hold	24,160	–	–	0.29%	34
2016 Q1	$2.51M	Hold	24,160	–	–	0.31%	36
2015 Q4	$2.36M	Buy	24,160 +400	+2%	+$39.2K	0.27%	38
2015 Q3	$2.29M	Buy	23,760 +960	+4%	+$101K	0.26%	39
2015 Q2	$2.39M	Sell	22,800 -9,600	-30%	-$981K	0.26%	40
2015 Q1	$3.34M	Hold	32,400	–	–	0.4%	33
2014 Q4	$3.12M	Hold	32,400	–	–	0.35%	37
2014 Q3	$2.58M	Sell	32,400 -250	-0.8%	-$19.7K	0.31%	37
2014 Q2	$2.46M	Hold	32,650	–	–	0.29%	35
2014 Q1	$2.44M	Hold	32,650	–	–	0.31%	36
2013 Q4	$2.34M	Hold	32,650	–	–	0.29%	36
2013 Q3	$1.85M	Buy	32,650 +750	+2%	+$44.7K	0.24%	42
2013 Q2	$1.82M	Buy	+31,900	New	+$1.85M	0.27%	39

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Cannell & Spears's CVS Position: Q2 2024 in Review

Cannell & Spears sold out of CVS Health (CVS) in Q2 2024, closing a stake of 9,995 shares — an estimated $797K sold.

Cannell & Spears first reported a position in CVS in Q2 2013 and held it in 44 quarters. The position peaked at $3.34M in Q1 2015. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

Cannell & Spears reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
Cannell & Spears sold 9,995 CVS Health shares in Q2 2024, an estimated $797K.
Cannell & Spears first reported a position in CVS Health in Q2 2013 and held it in 44 quarters.
Cannell & Spears's CVS Health position peaked at $3.34M in Q1 2015.
1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Cannell & Spears's 13F filing for Q2 2024, filed 12 Aug 2024.